- Home
- NIXX vs DXR Comparison
NIXX vs DXR Comparison
Compare NIXX & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- DXR
- Stock Information
- Founded
- NIXX 2010
- DXR 1970
- Country
- NIXX United States
- DXR United States
- Employees
- NIXX N/A
- DXR N/A
- Industry
- NIXX
- DXR Medical/Dental Instruments
- Sector
- NIXX
- DXR Health Care
- Exchange
- NIXX NYSE
- DXR Nasdaq
- Market Cap
- NIXX 49.9M
- DXR 46.1M
- IPO Year
- NIXX N/A
- DXR N/A
- Fundamental
- Price
- NIXX $1.90
- DXR $10.06
- Analyst Decision
- NIXX
- DXR Strong Buy
- Analyst Count
- NIXX 0
- DXR 1
- Target Price
- NIXX N/A
- DXR $25.00
- AVG Volume (30 Days)
- NIXX 321.4K
- DXR 3.1K
- Earning Date
- NIXX 08-13-2025
- DXR 01-01-0001
- Dividend Yield
- NIXX N/A
- DXR N/A
- EPS Growth
- NIXX N/A
- DXR 86.16
- EPS
- NIXX N/A
- DXR 0.11
- Revenue
- NIXX $1,786,387.00
- DXR $119,714.00
- Revenue This Year
- NIXX N/A
- DXR N/A
- Revenue Next Year
- NIXX N/A
- DXR N/A
- P/E Ratio
- NIXX N/A
- DXR $93.33
- Revenue Growth
- NIXX 54.16
- DXR N/A
- 52 Week Low
- NIXX $1.35
- DXR $6.55
- 52 Week High
- NIXX $8.50
- DXR $10.25
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- DXR 63.17
- Support Level
- NIXX N/A
- DXR $9.05
- Resistance Level
- NIXX N/A
- DXR $9.90
- Average True Range (ATR)
- NIXX 0.00
- DXR 0.35
- MACD
- NIXX 0.00
- DXR 0.04
- Stochastic Oscillator
- NIXX 0.00
- DXR 87.58
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.